Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00219882 · ClinicalTrials.gov registry record · Phase 1
Safety Study of Orally Administered Curcuminoids in Adult Subjects With Cystic Fibrosis
A Phase 1 study of Cystic Fibrosis, sponsored by Ramsey, Bonnie, MD.
- Completed
- Registry status
- Phase 1
- Development phase
- 11
- Enrollment target
- 2
- Study locations
NCT00219882: Completed Phase 1 study of Cystic Fibrosis, sponsored by Ramsey, Bonnie, MD.
NCT00219882 is a Phase 1 study of Cystic Fibrosis that has completed, run by Ramsey, Bonnie, MD. The registered enrollment target is 11 participants, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00219882, a Phase 1 study of Cystic Fibrosis, has completed, sponsored by Ramsey, Bonnie, MD.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 11 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to assess the safety of advancing doses of curcuminoids administered orally for fourteen consecutive days in adult subjects with cystic fibrosis (CF) who are homozygous for ΔF508 CFTR.
Conditions Studied
Interventions
- DRUG standardized turmeric root extract
Study Locations (2)
Maryland
- Johns Hopkins Hospital - Baltimore
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2005-04 |
| Est. Completion | 2006-01 |
| Phase | Phase 1 |
What the finished NCT00219882 record still lists
NCT00219882 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Cystic Fibrosis appearing as the primary indexed condition, and to 1 intervention - of which standardized turmeric root extract is the first listed.
NCT00219882 reports a single indexed study location in Maryland, Washington.
Frequently Asked Questions
What is clinical trial NCT00219882 about?
NCT00219882 is a clinical study titled "Safety Study of Orally Administered Curcuminoids in Adult Subjects With Cystic Fibrosis". The purpose of this study is to assess the safety of advancing doses of curcuminoids administered orally for fourteen consecutive days in adult subjects with cystic fibrosis (CF) who are homozygous for ΔF508 CFTR.
What is the current status of trial NCT00219882?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 11 participants. The study started on 2005-04. Estimated completion is 2006-01.
What conditions does trial NCT00219882 study?
This clinical trial studies the following conditions: Cystic Fibrosis.
What interventions are being tested in trial NCT00219882?
The interventions under investigation include: standardized turmeric root extract (DRUG).
Who is sponsoring clinical trial NCT00219882?
This trial is sponsored by Ramsey, Bonnie, MD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00219882 being conducted?
This trial has 2 study locations across Maryland, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cystic Fibrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00219882's enrollment target sits among peer trials
11 156th of 169 higher than 12 of 169 other Cystic Fibrosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cystic Fibrosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
RECRUITING · Phase 1
-
A Study Assessing KB407 for the Treatment of Cystic Fibrosis
RECRUITING · Phase 1
-
Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy Participants
RECRUITING · Phase 1
-
A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)
RECRUITING · Phase 1
-
Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis
RECRUITING · Phase 1
-
A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF)
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia